The World Health Organisation (WHO) says it approved R21/Matrix-M, a malaria vaccine, developed by scientists at Oxford University, for the prevention of the disease in children. In a statement on
Tag "High efficacy"
Advertisement
Advertisement
Advertisement
Advertisement
Top Stories
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Life and Living
Advertisement
Advertisement